Peer Review reports
From: CARD9 contributes to ovarian cancer cell proliferation, cycle arrest, and cisplatin sensitivity
| Original Submission | ||
|---|---|---|
| 19 Aug 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 15 Sep 2022 | Reviewed | Reviewer Report |
| 17 Sep 2022 | Reviewed | Reviewer Report - Jagpreet Singh Nanda |
| 30 Sep 2022 | Author responded | Author comments - Yanming Wang |
| Resubmission - Version 4 | ||
| 30 Sep 2022 | Submitted | Manuscript version 4 |
| 8 Oct 2022 | Author responded | Author comments - Yanming Wang |
| Resubmission - Version 5 | ||
| 8 Oct 2022 | Submitted | Manuscript version 5 |
| 14 Oct 2022 | Author responded | Author comments - Yanming Wang |
| Resubmission - Version 6 | ||
| 14 Oct 2022 | Submitted | Manuscript version 6 |
| 18 Oct 2022 | Reviewed | Reviewer Report |
| 31 Oct 2022 | Reviewed | Reviewer Report - Jagpreet Singh Nanda |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 1 Nov 2022 | Editorially accepted | |
| 28 Nov 2022 | Article published | 10.1186/s12860-022-00447-0 |
You can find further information about peer review here.